Compound 626
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C43H49ClN8O4S2/c1-49(2)22-18-34(29-57-36-9-4-3-5-10-36)47-40-17-16-37(26-42(40)52(53)54)58(55,56)48-43-39-21-25-51(28-41(39)45-30-46-43)35-19-23-50(24-20-35)27-32-8-6-7-11-38(32)31-12-14-33(44)15-13-31/h3-17,26,30,34-35,47H,18-25,27-29H2,1-2H3,(H,45,46,48)/t34-/m1/s1
- InChiKey:
DEMZCGDYHDAZDJ-UUWRZZSWSA-N
External links
67980999 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 1 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 840.30 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.00 | |||
TPSA | 139.52 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 1 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4103 | GDC-0349 | DB13072 | |
0.4103 | Navitoclax | DB12340 | |
0.4034 | Sulfaisodimidine | DB13283 | |
0.3872 | Presatovir | DB12165 | |
0.3724 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3696 | 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | DB07585 | |
0.3684 | Sparsentan | DB12548 | |
0.3661 | Quinupristin | DB01369 | |
0.3656 | Venetoclax | DB11581 | |
0.3643 | PF-03814735 | DB13059 | |
0.3614 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3614 | Tianeptine | DB09289 | |
0.3611 | (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | DB07666 | |
0.3608 | Tasosartan | DB01349 | |
0.3599 | CH-5132799 | DB13051 |